Biotechnology

Alps

Alps released FY2024 Annual Earnings on July 25 Post-Market (EST), actual revenue USD 2.404 M, actual EPS USD -0.0481

Alps released FY2025 Q4 earnings on July 25 (EST), actual revenue USD 770.68K, actual EPS USD -0.0115

Alps released FY2024 Q3 earnings on July 25 (EST), actual revenue USD 561.66 K, actual EPS USD -0.0147

Alps released FY2025 9 Months earnings on July 25 (EST), actual revenue USD 2.6 M, actual EPS USD -0.0317

Alps released FY2025 Annual Earnings on July 25 Post-Market (EST), actual revenue USD 3.371 M, actual EPS USD -0.0433

Alps released FY2025 Q3 earnings on July 25 (EST), actual revenue USD 770.68 K, actual EPS USD -0.0115

Alps released FY2024 Q4 earnings on July 25, 2025 (EST) with actual revenue of USD 561.66K and EPS of USD -0.0147

Alps released FY2024 9 Months Earnings on July 25 (EST), actual revenue USD 1.842 M, actual EPS USD -0.033

Alps released FY2025 Q1 earnings on April 1 (EST), actual revenue USD 914.84K, actual EPS USD -0.01

Alps released FY2025 Semi-Annual earnings on April 1 (EST), actual revenue USD 1.83 M, actual EPS USD -0.0201

Alps released FY2024 Q2 earnings on April 1, 2025 (EST) with actual revenue of USD 640.11K and EPS of USD -0.0091

Alps released FY2024 Semi-Annual earnings on April 1, 2025 (EST), with actual revenue of USD 1.28 M and EPS of USD -0.0182

Alps released FY2024 Q1 earnings on April 1 (EST), actual revenue USD 640.12 K, actual EPS USD -0.0091

Alps released FY2025 Q2 earnings on April 1 (EST) with actual revenue of USD 914.84K and EPS of USD -0.01

Sobr Safe

Omeros

Northann

AMC Robotics

Euda Health

Dynavax Tech

Multi Ways

Indaptus Therapeutics

Sidus Space

Kandal M Venture

Adma Biologics

Kiniksa Pharmaceuticals

Stoke Therapeutics

Rigel Pharma

OpGen

Vertex Pharma

Regeneron Pharma

Alnylam Pharma

Argenx

Beigene

Style Score

Growth Score

Revenue YoY

Net Profit YoY

Value Score

P/B Ratio

Dividend Ratio

Size Score

Market Cap Score

Market Cap

Revenue Score

Revenue

Multi Score

Profit Score

Profit Margin

Gross Margin

Total Assets YoY

Net Assets YoY

Cash Score

Cash Flow Margin

OCF YoY

Operating Score

Turnover

Debt Score

Gearing Ratio

Please note that a "Suspected value trap" is a stock that appears The stock looks financially sound and severely undervalued, but behind the low valuation is a long-term decline in business capacity or a serious financial crisis, or even the risk of bankruptcy in the short term.

Suspected value trap